Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma

被引:95
作者
Chen, Xiaoyue [1 ]
Yan, Qin [1 ]
Li, Shuangdi [2 ]
Zhou, Long [1 ]
Yang, Huajing [1 ]
Yang, Yixia [2 ]
Liu, Xuelian [2 ]
Wan, Xiaoping [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China
关键词
Endometrial endometrioid adenocarcinoma (EEC); MicroRNA-206 (miR-206); Estrogen receptor alpha (ER alpha); ESTROGEN-RECEPTOR-ALPHA; PROMOTING PROLIFERATION; ESR1; AMPLIFICATION; MESSENGER-RNA; CANCER; CARCINOMA; MICRORNA; GRADE; MMP-2;
D O I
10.1016/j.canlet.2011.09.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
This study investigated the role of miR-206 in estrogen receptor-alpha (ER alpha)-positive endometrial endometrioid adenocarcinoma (EEC). We profiled miR-206 expression in 30 EEC clinical samples using qRT-PCR, and explored its relationship with ER alpha and clinical parameters. A luciferase reporter assay assessed the ER alpha targeting potential of miR-206. Functional analyses of miR-206 were performed in EEC cell lines. MiRNA-206 expression decreased in ER alpha-positive EECs, and its expression was negatively correlated with ER alpha. MiRNA-206 overexpression inhibited ER alpha-dependent proliferation, impaired invasiveness and induced cell cycle arrest of ER alpha-positive EEC cell lines. Therefore, aberrantly expressed miRNA-206 may be associated with the development of ER alpha-positive EEC. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:41 / 53
页数:13
相关论文
共 44 条
[1]
The Revised 2009 FIGO Staging System for Endometrial Cancer Should the 1988 FIGO Stages IA and IB Be Altered? [J].
Abu-Rustum, Nadeem R. ;
Zhou, Qin ;
Iasonos, Alexia ;
Alektiar, Kaled M. ;
Leitao, Mario M., Jr. ;
Chi, Dennis S. ;
Sonoda, Yukio ;
Soslow, Robert ;
Hensley, Martee ;
Barakat, Richard R. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (03) :511-516
[2]
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines [J].
Adams, Brian D. ;
Furneaux, Henry ;
White, Bruce A. .
MOLECULAR ENDOCRINOLOGY, 2007, 21 (05) :1132-1147
[3]
The Role of miR-206 in the Epidermal Growth Factor (EGF) Induced Repression of Estrogen Receptor-α (ERα) Signaling and a Luminal Phenotype in MCF-7 Breast Cancer Cells [J].
Adams, Brian D. ;
Cowee, Danielle M. ;
White, Bruce A. .
MOLECULAR ENDOCRINOLOGY, 2009, 23 (08) :1215-1230
[4]
Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer -: MMP-9 correlates to the grade and the stage [J].
Aglund, K ;
Rauvala, M ;
Puistola, U ;
Ångström, T ;
Turpeenniemi-Hujanen, T ;
Zackrisson, B ;
Stendahl, U .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :699-704
[5]
Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? [J].
Alektiar, KM ;
McKee, A ;
Lin, O ;
Venkatraman, E ;
Zelefsky, MJ ;
McKee, B ;
Hoskins, WJ ;
Barakat, RR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01) :79-85
[6]
microRNAs: Tiny regulators with great potential [J].
Ambros, V .
CELL, 2001, 107 (07) :823-826
[7]
Tamoxifen-Induced Adduct Formation and Cell Stress in Human Endometrial Glands [J].
Andersson, Helen ;
Helmestam, Malin ;
Zebrowska, Anna ;
Olovsson, Matts ;
Brittebo, Eva .
DRUG METABOLISM AND DISPOSITION, 2010, 38 (01) :200-207
[8]
Endometrioid carcinoma of the endometrium: pathologic and molecular features [J].
Azueta, Ainara ;
Gatius, Sonia ;
Matias-Guiu, Xavier .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2010, 27 (04) :226-240
[9]
2 PATHOGENETIC TYPES OF ENDOMETRIAL CARCINOMA [J].
BOKHMAN, JV .
GYNECOLOGIC ONCOLOGY, 1983, 15 (01) :10-17
[10]
An estrogen receptor-Lu splicing variant mediates both positive and negative effects on gene transcription [J].
Bollig, A ;
Miksicek, RJ .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (05) :634-649